Rob,
It is a Biotech norm that it WILL BE and HAD TO BE a pharma to make licensing and partnering deals with Biotech companies.
Similar to TEVA on ATL1102.
Pfizer on EXC001
Genzyme on Mipomersen
Biogen Idec on Isis-SMN
It is only looked misleading to you if you don't see the difference or make no difference in any of the info available.
- Forums
- ASX - By Stock
- PER
- reversal
reversal, page-112
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $81.90M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.9¢ | $25.01K | 313.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 349993 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 218650 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 349993 | 0.079 |
20 | 1595307 | 0.078 |
11 | 1092406 | 0.077 |
5 | 348071 | 0.076 |
10 | 1052416 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 218650 | 1 |
0.081 | 382608 | 3 |
0.082 | 150000 | 1 |
0.083 | 431250 | 4 |
0.084 | 200000 | 1 |
Last trade - 10.43am 04/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |